Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Intraday Update
  • Markets
  • News

A Look Into Agilent Technologies Inc’s Price Over Earnings

By Benzinga Insights
Today, 11:25 PM
Looking into the current session, Agilent Technologies Inc. (NYSE:A) shares are trading at $138.38, after a 0.01% decrease.…

A

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Looking Into Agilent Technologies’s Recent Short Interest

By Benzinga Insights
Today, 11:25 PM
Agilent Technologies's (NYSE:A) short percent of float has fallen 5.0% since its last report. The company recently reported that it has 2.99 million shares sold short, which is 1.14% of all regular shares that are available for trading.

A

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much You Would Have Made Owning Agilent Technologies Stock In The Last 5 Years

By Benzinga Insights
Today, 11:25 PM
Agilent Technologies (NYSE:A) has outperformed the market over the past 5 years by 7.32% on an annualized basis…

A

Read More
2 minute read
  • Contracts
  • News

Colorado Governor Polis Helps Agilent Break Ground On $725M Expansion Of Manufacturing Operations In Frederick

By Happy Mohamed
Today, 11:25 PM
Leaders from Agilent Technologies Inc. (NYSE:A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent's $725 million investment to double manufacturing

A

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth Today

By Benzinga Insights
Today, 11:25 PM
Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 3.12% on an annualized basis…

A

Read More
22 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For January 10, 2023

By Benzinga Insights
Today, 11:25 PM
Upgrades Morgan Stanley upgraded the previous rating for Stem Inc (NYSE:STEM) from Equal-Weight to Overweight. In the third…

A

Read More
1 minute read
  • Analyst Ratings

Analyst Ratings for Agilent Technologies

By Benzinga Insights
Today, 11:25 PM
Agilent Technologies (NYSE:A) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

A

Read More
2 minute read
  • General
  • Global
  • News
  • Politics

Ukraine’s Zelenskyy Slams Olympics’ ‘Neutral Flag’ Idea For Putin’s Athletes: ‘All Their Flags Are Stained With Blood’

By Navdeep Yadav
Today, 11:25 PM
Ukrainian President Volodymyr Zelenskyy urged the International Olympic Committee not to allow Russian athletes to compete in sporting…

A

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

Reported Late Monday, Agilent Resolution ctDx FIRST Receives FDA Approval As A Liquid Biopsy Companion Diagnostic Test For Advanced Non-small Cell Lung Cancer

By Benzinga Newsdesk
Today, 11:25 PM
Agilent Technologies Inc. (NYSE:A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung

A

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
Today, 11:25 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

A

Posts navigation

1 2 … 15 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service